📰 13 sources covering this story

More than 150 deaths reported after weight loss drug use

First covered 2 days ago · latest take 1 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

More than 150 deaths reported after weight loss drug use
More than 150 deaths reported after weight loss drug use
Most complaints about GLP-1 drugs made through the MHRA’s Yellow Card scheme were concerning gastrointestinal reactions
The Mirror
The Mirror5 hrs ago
'Do not buy this product' Dr Amir Khan weight loss drug warning message
The NHS GP is urging people to avoid the product after he received messages about it from followers and family members
Euronews
Euronews9 hrs ago
Weight-loss drugs tied to lower fracture risk in diabetes patients, study finds
Weight-loss medicines linked to 21% lower fracture risk in type 2 diabetes patients, a new study found, challenging assumptions that rapid weight loss inevitably raises fracture risk.
The Times
The Times19 hrs ago
Pancreatitis — how great is the risk of weight-loss medication?
Pancreatitis — how great is the risk of weight-loss medication?  The Times
Quartz
Quartz21 hrs ago
Bank of America is spending $250 million a year on weight loss drugs for employees
CEO Brian Moynihan says GLP-1 medications now account for roughly 13% of the bank's total annual healthcare spending
MarketWatch
MarketWatch21 hrs ago
How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?
The Danish company developed the most lucrative new drug the world had ever seen. Then America’s Eli Lilly outmaneuvered it and took control of the diet-drug market.
New York Post
New York Post23 hrs ago
Some patients to score new super-effective ‘Triple G’ weight loss drug — before FDA approval
Retatrutide — also known as "reta" — has been shown to produce dramatically greater weight loss than Ozempic and Mounjaro.
CNBC
CNBC1 days ago
Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says
Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.
We can help frogs beat a deadly disease. But can they still reproduce?
Many people are blissfully unaware the world’s frogs and amphibians are fighting their own deadly pandemic. In fact, this fungal disease – chytridiomycosis, or chytrid for short – is the worst wildlife disease on record. The chytrid fungus has caused the global extinction of 90 amphibian species and affected nearly 30
RNZ
RNZ1 days ago
Weight loss drugs could boost chances of getting a job
International research suggests losing weight may help people get a job - and their New Zealand counterparts say it can't be ruled out here, either.
CBS News
CBS News2 days ago
Access expanding for experimental weight loss drug
Drugmaker Eli Lilly says it is expanding access to its experimental weight loss drug, retatrutide, which has not been approved yet by the FDA. The company says obese patients taking the drug in clinical trials lost between 73 and 85 pounds over two years. Dr. Rachel Pessah Pollack discusses what we know about its safet
Fox News
Fox News2 days ago
Popular weight-loss drugs may help protect against a deadly disease, doctor says
A breast cancer surgeon explains how GLP-1 drugs like Ozempic and Wegovy may lower cancer recurrence risk by reducing BMI, estrogen and inflammation.
Stuff
Stuff🏁 first to report2 days ago
‘My doctor said I could die’: Flight attendant lost a quarter of her body weight after taking illegal weight loss drugs
Jaime says TikTok taught her how to buy and inject black market peptides. Months later, she had lost 17kg.